← Evidence map

TrialNature medicine2026

High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.

Richard S Finkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41634391